April 7th 2021

Q&A on the Commercialisation of Healthcare in Sweden

Thomson Reuters has published a Q&A on the topic of Commercialisation of healthcare in Sweden, written by Mina Gholiof. Hellström Law regularly assists clients within the life sciences sector in various matters such as negotiations on agreements on clinical trials and distribution agreements, as well as marketing issues and matters relating to the ethical rules applicable to the industry.

Please consult the Q&A for a high-level overview of the regulatory framework for the commercialisation of medicinal products and medical devices in Sweden, and contact Mina Gholiof  for further information.